vancomycin aptapharma 1000 mg proszek do sporządzania koncentratu roztworu do infuzji
apta medica international d.o.o. - vancomycini hydrochloridum - proszek do sporządzania koncentratu roztworu do infuzji - 1000 mg
vancomycin aptapharma 500 mg proszek do sporządzania koncentratu roztworu do infuzji
apta medica international d.o.o. - vancomycini hydrochloridum - proszek do sporządzania koncentratu roztworu do infuzji - 500 mg
tecvayli
janssen-cilag international n.v. - teclistamab - szpiczak mnogi - Środki przeciwnowotworowe - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
rivaroxaban farmak 20 mg tabletki powlekane
farmak international sp. z o.o. - rivaroxabanum - tabletki powlekane - 20 mg
rivaroxaban farmak 15 mg tabletki powlekane
farmak international sp. z o.o. - rivaroxabanum - tabletki powlekane - 15 mg
talvey
janssen-cilag international n.v. - talquetamab - szpiczak mnogi - Środki przeciwnowotworowe - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
durogesic 25 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 25 mcg/h
durogesic 50 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 50 mcg/h
durogesic 75 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 75 mcg/h
durogesic 100 mcg/h system transdermalny
janssen-cilag international n.v. - fentanylum - system transdermalny - 100 mcg/h